Copyright
©The Author(s) 2001.
World J Gastroenterol. Feb 15, 2001; 7(1): 42-48
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.42
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.42
Groups | 2g* | 2s* | SSS△ |
Normal control group | 1.00 ± 0.00 | 1.00 ± 0.00 | 0 |
Fibrotic model group | 7.00 ± 2.16 | 9.60 ± 4.70 | 12.60 ± 3.57 |
Colchicine treatment group | 6.80 ± 4.13 | 7.00 ± 3.92a | 11.30 ± 2.37a |
High-dose IFN-γ group | 6.40 ± 2.07 | 2.60 ± 0.97bc | 6.30 ± 0.48bc |
Medium-dose IFN-γ group | 4.80 ± 2.35 | 4.00 ± 2.32bc | 8. 10 ± 2.72bc |
Low-dose IFN-γ group | 5.00 ± 2.71 | 4.40 ± 2.07bc | 8.30 ± 2.58bc |
- Citation: Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis. World J Gastroenterol 2001; 7(1): 42-48
- URL: https://www.wjgnet.com/1007-9327/full/v7/i1/42.htm
- DOI: https://dx.doi.org/10.3748/wjg.v7.i1.42